Access cutting-edge type 1 diabetes (t1d) treatment through this phase 2 clinical trial at a research site in Aurora. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Aurora location
Preparing your pre-screening questions…
Access type 1 diabetes (t1d) specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related type 1 diabetes (t1d) treatment provided free
Check if you qualify for this type 1 diabetes (t1d) clinical trial in Aurora, CO
No-Cost Study Care
Local to Aurora
Convenient for CO residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
TTP399-206 is a Phase 2a multicenter double blind cross over randomized study of cadisegliatin in participants with T1D using hybrid closed loop systems to manage their diabetes. Participants using a hybrid closed loop insulin pump to manage their diabetes will be randomized to either receive blinded cadisegliatin 800 mg QD as an adjunctive therapy to their insulin treatment or placebo QD along with their insulin treatment. The trial begins with a screening period of up to 2 weeks, followed by a device training and insulin adjustment period of 1-2 weeks leading into the first double-blind treatment period of 6 weeks. There will then be a washout period of 2 weeks followed by the second double-blind treatment period of 6 weeks where the participants will cross-over to the treatment that they did not receive in the first treatment period.
Sponsor: vTv Therapeutics
Yes, this clinical trial (NCT07616206) has an active research site in Aurora, CO that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for type 1 diabetes (t1d) treatment options in Aurora, CO, this clinical trial (NCT07616206) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Aurora research site is actively enrolling participants for this phase 2 clinical trial. You'll receive care from experienced type 1 diabetes (t1d) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all type 1 diabetes (t1d) clinical trials near you to find additional studies recruiting in your area.
See all pulmonary embolism clinical trials recruiting in Aurora — not just this study.
Browse Pulmonary Embolism Trials in Aurora →